Company news
Tomahawk Metals Plc (AQUIS:TMHK) news
Tomahawk Metals Plc news releases on 6ix. Latest, Oct 2, 2026: Total Voting Rights
Press releases & updates
Total Voting Rights
October 2, 2026
Holding(s) in Company and Warrants Correction
September 30, 2026
Holding(s) in Company and Warrants Correction
September 30, 2026
£137k Fundraise, Warrants & Adviser Change
September 24, 2026
Issue of Equity - Replacement
September 21, 2026
Issue of Equity
September 17, 2026
Slovakian Desk Research & Licences Transferred
September 14, 2026
HIGH-GRADE ROCK-CHIP GOLD RESULTS FROM SATURN GOLD
September 1, 2026
Saturn Gold Project Update: New Gold Targets
August 12, 2026
Strategic and Operational update & TVR
July 1, 2026
Slovakian Asset due diligence Completed
June 17, 2026
Gold Acquisition Completed, Slovakian Asset & TVR
June 3, 2026
Name Change, Board Change and Company Update
May 18, 2026
Total Voting Rights & Update of Fundraising
April 30, 2026
Holding(s) in Company
April 24, 2026
BOARD APPOINTMENT, FUND RAISE & OPTION AGREEMENTS
April 20, 2026
Interim Results to 31 October 2025
January 30, 2026
Symposium: Shortwave Presenting Clinical Research
December 2, 2025
Patent Application Publication
November 6, 2025
AGM, Treasury Policy & Capital Reorganisation
November 4, 2025
ANNUAL REPORT AND ACCOUNTS TO 30 APRIL 2025
October 31, 2025
Appointment of Aquis Corporate Adviser
October 15, 2025
Appointment digital asset treasury partner Archax
September 26, 2025
Direction, Director Changes and Medical Adviser
September 10, 2025
Clarification on Strategic Advisor Appointment
August 4, 2025
£250k Fundraising, New Directors & Review
July 29, 2025
AQSE Only - Holding(s) in Company
June 24, 2025
£40,000 Placing
June 10, 2025
Interim Results to 31 October 2024
January 31, 2025
Pre-Crowdfunding re Groundbreaking Treatment
December 23, 2024
Total Voting Rights
November 29, 2024
Director Appointment and SPA Update
November 27, 2024
YEAR ENDED 30 APRIL 2024 AND DIRECTOR RESIGNATION
October 31, 2024
Positive Pre-Clinical Result Drive to Human Trials
September 19, 2024
TR1: Notification of Major Holdings
July 17, 2024
Company’s Patent Claims Confirmed
July 8, 2024
Name Change Rebranding and Share Option Update
June 6, 2024
Board Resignation, Role Change and Option Grant
April 5, 2024
Operational Update, Share Options and Share Issue
February 2, 2024
Interim Results to 31 October 2023
January 30, 2024
Board Changes and Shortwave Pharma Completion
November 7, 2023
AUDITED RESULTS FOR THE YEAR ENDED 30 APRIL 2023
October 31, 2023
PSYCH Symposium 2023
July 7, 2023
PSYCH Symposium 2023: 6th July 2023
June 22, 2023
Acquisition of Short Wave Pharma for £3.5m
June 19, 2023